These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27320498)

  • 1. Influence of Genetic Polymorphisms and Concomitant Anxiolytic Doses on Antidepressant Maintenance Doses in Japanese Patients with Depression.
    Inoue K; Murofushi T; Nagaoka K; Ando N; Hakamata Y; Suzuki A; Umemura A; Yoshida Y; Hirai K; Tsuji D; Itoh K
    Biol Pharm Bull; 2016 Sep; 39(9):1508-13. PubMed ID: 27320498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.
    Murphy GM; Sarginson JE; Ryan HS; O'Hara R; Schatzberg AF; Lazzeroni LC
    Pharmacogenet Genomics; 2013 Jun; 23(6):301-13. PubMed ID: 23619509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression.
    Wilkie MJ; Smith D; Reid IC; Day RK; Matthews K; Wolf CR; Blackwood D; Smith G
    Pharmacogenet Genomics; 2007 Mar; 17(3):207-15. PubMed ID: 17460549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of DNA methylation in BDNF with escitalopram treatment response in depressed Chinese Han patients.
    Wang P; Zhang C; Lv Q; Bao C; Sun H; Ma G; Fang Y; Yi Z; Cai W
    Eur J Clin Pharmacol; 2018 Aug; 74(8):1011-1020. PubMed ID: 29748862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
    Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
    Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype distributions and allele frequencies of possible major depressive disorder-associated single nucleotide polymorphisms, cyclic adenosine monophosphate response element binding protein 1 rs4675690 and Piccolo rs2522833, in a Japanese population.
    Inoue K; Ando N; Suzuki E; Hayashi H; Tsuji D; Itoh K
    Biol Pharm Bull; 2012; 35(2):265-8. PubMed ID: 22293360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain‑derived neurotrophic factor gene polymorphisms are associated with coronary artery disease‑related depression and antidepressant response.
    Liu YQ; Su GB; Duan CH; Wang JH; Liu HM; Feng N; Wang QX; Liu XE; Zhang J
    Mol Med Rep; 2014 Dec; 10(6):3247-53. PubMed ID: 25324022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
    Domschke K; Lawford B; Laje G; Berger K; Young R; Morris P; Deckert J; Arolt V; McMahon FJ; Baune BT
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):93-101. PubMed ID: 19236730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
    Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response.
    Su N; Zhang L; Fei F; Hu H; Wang K; Hui H; Jiang XF; Li X; Zhen HN; Li J; Cao BP; Dang W; Qu Y; Zhou F
    Brain Res; 2011 Sep; 1415():119-26. PubMed ID: 21880305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
    Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
    Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is agmatine an endogenous anxiolytic/antidepressant agent?
    Aricioglu F; Altunbas H
    Ann N Y Acad Sci; 2003 Dec; 1009():136-40. PubMed ID: 15028578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
    Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter polymorphisms of SERPINE1 are associated with the antidepressant response to depression in Alzheimer's disease.
    Fang Y; Zhang L; Zeng Z; Lian Y; Jia Y; Zhu H; Xu Y
    Neurosci Lett; 2012 May; 516(2):217-20. PubMed ID: 22503724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor.
    Yasuda S; Yoshida M; Yamagata H; Iwanaga Y; Suenaga H; Ishikawa K; Nakano M; Okuyama S; Furukawa Y; Furukawa S; Ishikawa T
    Cell Mol Neurobiol; 2014 Nov; 34(8):1199-208. PubMed ID: 25156823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic, antidepressant, and antistress activities of the aqueous extract of
    Upadhyay G; Khoshla S; Kosuru R; Singh S
    Indian J Pharmacol; 2016; 48(5):555-561. PubMed ID: 27721543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.
    Schmidt HD; Duman RS
    Neuropsychopharmacology; 2010 Nov; 35(12):2378-91. PubMed ID: 20686454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW; Jue SG; Brogden RN
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.